KOSDAQ - Delayed Quote KRW

ORGANOIDSCIENCES (476040.KQ)

40,950.00
-4,600.00
(-10.10%)
At close: May 23 at 3:30:22 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,953,269.92
1,953,269.92
1,591,048.39
438,240.71
270,251.36
Gross Profit
1,953,269.92
1,953,269.92
1,591,048.39
438,240.71
270,251.36
Operating Expense
14,188,238.28
14,188,238.28
11,385,882.68
10,990,806.67
4,982,508.58
Operating Income
-12,234,968.36
-12,234,968.36
-9,794,834.29
-10,552,565.96
-4,712,257.22
Net Non Operating Interest Income Expense
-2,708,876.68
-2,708,876.68
-5,067,115.37
-4,323,913.68
-1,052,552.68
Pretax Income
-11,535,516.68
-11,535,516.68
-38,868,144.42
-24,111,281.70
-17,615,081.65
Net Income Common Stockholders
-11,246,456
-11,246,456
-38,687,287
-24,111,281.70
-17,615,081.65
Basic EPS
-2.69k
--
-13.56k
-8.41k
-6.21k
Diluted EPS
-2.69k
--
-13.56k
-8.41k
-6.21k
Basic Average Shares
4,179.29
--
2,852.41
2,865.96
2,837.94
Diluted Average Shares
4,179.29
--
2,852.41
2,865.96
2,837.94
Total Operating Income as Reported
-12,234,968.46
-12,234,968.46
-9,794,834.38
-10,552,566.05
-4,712,257.29
Rent Expense Supplemental
254,874.60
254,874.60
135,396.53
26,950.63
3,815.54
Total Expenses
14,188,238.28
14,188,238.28
11,385,882.68
10,990,806.67
4,982,508.58
Net Income from Continuing & Discontinued Operation
-11,246,456
-11,246,456
-38,687,287
-24,111,281.70
-17,615,081.65
Normalized Income
-14,477,630.50
-14,477,630.50
-14,616,741.36
-14,799,433.81
-5,734,940.44
Interest Income
481,100.70
481,100.70
924,750.31
582,064.58
17,264.58
Interest Expense
3,189,977.40
3,189,977.40
5,991,865.69
4,905,978.26
1,069,817.25
Net Interest Income
-2,708,876.68
-2,708,876.68
-5,067,115.37
-4,323,913.68
-1,052,552.68
EBIT
-8,345,539.28
-8,345,539.28
-32,876,278.73
-19,205,303.44
-16,545,264.40
EBITDA
-7,041,806.28
-7,041,806.28
-31,732,092.16
-18,400,841.02
-16,282,491.02
Reconciled Depreciation
1,303,733
1,303,733
1,144,186.57
804,462.42
262,773.38
Net Income from Continuing Operation Net Minority Interest
-11,246,456
-11,246,456
-38,687,287
-24,111,281.70
-17,615,081.65
Total Unusual Items Excluding Goodwill
3,231,174.50
3,231,174.50
-24,070,545.64
-9,311,847.89
-11,880,141.21
Total Unusual Items
3,231,174.50
3,231,174.50
-24,070,545.64
-9,311,847.89
-11,880,141.21
Normalized EBITDA
-10,272,980.78
-10,272,980.78
-7,661,546.52
-9,088,993.13
-4,402,349.81
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/9/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

394800.KQ 3billion
6,500.00
-2.26%
 
603392.SS Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
68.10
-0.42%
 
002287.SZ Tibet Cheezheng Tibetan Medicine Co., Ltd.
24.46
+0.45%
 
053030.KQ BINEX Co., Ltd.
18,350.00
-3.06%
 
688331.SS RemeGen Co., Ltd.
57.83
+2.08%
 
087010.KQ Peptron, Inc.
220,000.00
+5.01%
 
2162.HK Keymed Biosciences Inc.
40.300
-0.98%
 
1952.HK Everest Medicines Limited
42.700
-1.39%
 
6660.HK AIM Vaccine Co., Ltd.
4.060
-2.17%
 
2171.HK CARsgen Therapeutics Holdings Limited
20.400
-10.13%